{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:09:16Z","timestamp":1792411756402,"version":"4.4.0"},"reference-count":81,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijdvl.ijdvl_33_18","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T11:35:56Z","timestamp":1537529756000},"page":"652","source":"Crossref","is-referenced-by-count":62,"title":["N-acetylcysteine in dermatology"],"prefix":"10.25259","volume":"84","author":[{"given":"Mohammad","family":"Adil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SyedSuhail","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Mohtashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.241953-1","first-page":"CD003328","article-title":"Interventions for paracetamol (acetaminophen) overdose","author":"Brok","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0378-6323.241953-2","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility","author":"Dodd","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.4103\/0378-6323.241953-3","first-page":"265","article-title":"N-acetylcysteine: Multiple clinical applications","author":"Millea","year":"2009","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/0378-6323.241953-4","unstructured":"N-acetyl-L-cysteine. National Center for Biotechnology Information. Pubchem Compound Database; CID 12035. Available from: https:\/\/www.pubchem.ncbi.nlm.nih.gov\/compound\/12035. [Last accessed on 2017 Dec 20]."},{"key":"key-10.4103\/0378-6323.241953-5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: Mechanisms of action and therapeutic opportunities","author":"Bavarsad","year":"2014","journal-title":"Brain Behav"},{"key":"key-10.4103\/0378-6323.241953-6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0378-6323.241953-7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1055\/s-0037-1614331","article-title":"Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor","author":"Sarker","year":"1999","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0378-6323.241953-8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1525-1470.2011.01375.x","article-title":"Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis","author":"Bassotti","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0378-6323.241953-9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","article-title":"The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress","author":"Kerksick","year":"2005","journal-title":"J Int Soc Sports Nutr"},{"key":"key-10.4103\/0378-6323.241953-10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-acetylcysteine \u2013 A safe antidote for cysteine\/glutathione deficiency","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.4103\/0378-6323.241953-11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action","author":"Dean","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"key-10.4103\/0378-6323.241953-12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: A placebo-controlled study","author":"Nascimento","year":"2010","journal-title":"Perit Dial Int"},{"key":"key-10.4103\/0378-6323.241953-13","doi-asserted-by":"crossref","first-page":"716458","DOI":"10.1155\/2008\/716458","article-title":"Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: A potential neuroprotective mechanism of N-acetylcysteine","author":"Chen","year":"2008","journal-title":"Mediators Inflamm"},{"key":"key-10.4103\/0378-6323.241953-14","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1089\/ars.2009.2463","article-title":"Redox regulation of nuclear post-translational modifications during NF-kappaB activation","author":"Gloire","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"key-10.4103\/0378-6323.241953-15","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","author":"Moran","year":"2005","journal-title":"J Neurosci"},{"key":"key-10.4103\/0378-6323.241953-16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/bmc.1171","article-title":"The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography","author":"Gere-P\u00e1szti","year":"2009","journal-title":"Biomed Chromatogr"},{"key":"key-10.4103\/0378-6323.241953-17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/taap.1997.8361","article-title":"Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine","author":"Sekharam","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"key-10.4103\/0378-6323.241953-18","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0140-6736(99)04245-2","article-title":"Topical N-acetylcysteine for lamellar ichthyosis","author":"Redondo","year":"1999","journal-title":"Lancet"},{"key":"key-10.4103\/0378-6323.241953-19","first-page":"669","article-title":"Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations","author":"Allegra","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"key-10.4103\/0378-6323.241953-20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mjd.2002.118557","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","author":"V\u00e9lez","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.241953-21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2133.1994.tb13130.x","article-title":"Toxic epidermal necrolysis.Treatment with pentoxifylline","author":"Redondo","year":"1994","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.241953-22","first-page":"931528","article-title":"Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteine","author":"Saavedra","year":"2012","journal-title":"Case Reports Immunol"},{"key":"key-10.4103\/0378-6323.241953-23","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1111\/ped.12410","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","author":"Yavuz","year":"2014","journal-title":"Pediatr Int"},{"key":"key-10.4103\/0378-6323.241953-24","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.burns.2014.01.027","article-title":"Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis.A proof-of-concept study","author":"Paquet","year":"2014","journal-title":"Burns"},{"key":"key-10.4103\/0378-6323.241953-25","first-page":"CS57","article-title":"Treatment of DIHS\/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir \u2013 A hypothesis","author":"Moling","year":"2012","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/0378-6323.241953-26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): A clinical update and review of current thinking","author":"Walsh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.241953-27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1592\/phco.31.10.1043","article-title":"Successful treatment of sulfasalazine-induced DRESS syndrome with corticosteroids and N-acetylcysteine","author":"Jose","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0378-6323.241953-28","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1528-1167.2008.01720.x","article-title":"Anticonvulsant hypersensitivity syndrome: Is there a role for immunomodulation?","author":"Cumbo-Nacheli","year":"2008","journal-title":"Epilepsia"},{"key":"key-10.4103\/0378-6323.241953-29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.jcp.0000264976.86990.00","article-title":"N-acetyl cysteine in the treatment of grooming disorders","author":"Odlaug","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/0378-6323.241953-30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0378-6323.241953-31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0974-7753.100090","article-title":"N-acetylcysteine in the treatment of trichotillomania","author":"Rodrigues-Barata","year":"2012","journal-title":"Int J Trichology"},{"key":"key-10.4103\/0378-6323.241953-32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/bjd.13080","article-title":"N-acetylcysteine in trichotillomania: A panacea for compulsive skin disorders?","author":"Taylor","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.241953-33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaac.2012.12.020","article-title":"N-acetylcysteine in the treatment of pediatric trichotillomania: A randomized, double-blind, placebo-controlled add-on trial","author":"Bloch","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key-10.4103\/0378-6323.241953-34","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/NDT.S121138","article-title":"Excoriation (skin-picking) disorder: A systematic review of treatment options","author":"Lochner","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key-10.4103\/0378-6323.241953-35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajmg.a.36306","article-title":"An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome","author":"Miller","year":"2014","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/0378-6323.241953-36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2016.0060","article-title":"N-acetylcysteine in the treatment of excoriation disorder: A randomized clinical trial","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"key-10.4103\/0378-6323.241953-37","first-page":"AB117","article-title":"Trichotillosis, skin picking and N-acetylcysteine","author":"Taylor","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.241953-38","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.jaad.2017.06.154","article-title":"Onychophagia and onychotillomania can be effectively managed","author":"Magid","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.241953-39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1871523011312030003","article-title":"N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial","author":"Ghanizadeh","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"key-10.4103\/0378-6323.241953-40","first-page":"245","article-title":"Topical N-acetylcysteine treatment in neonatal ichthyosis","author":"Sarici","year":"2003","journal-title":"Turk J Pediatr"},{"key":"key-10.4103\/0378-6323.241953-41","doi-asserted-by":"crossref","unstructured":"Deffenbacher B. Successful experimental treatment of congenital ichthyosis in an infant. BMJ Case Rep 2013;2013. pii: bcr2013008688.","DOI":"10.1136\/bcr-2013-008688"},{"key":"key-10.4103\/0378-6323.241953-42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/pde.12305","article-title":"Topical N-acetylcysteine for the treatment of lamellar ichthyosis: An improved formula","author":"Davila-Seijo","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0378-6323.241953-43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ajpath.2012.06.005","article-title":"Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies","author":"Nakai","year":"2012","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0378-6323.241953-44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5021\/ad.2015.27.4.450","article-title":"Effects of topical N-acetylcysteine on skin hydration\/Transepidermal water loss in healthy volunteers and atopic dermatitis patients","author":"Nakai","year":"2015","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.241953-45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/1523-1747.ep12384093","article-title":"Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactions","author":"Senaldi","year":"1994","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.241953-46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000424316","article-title":"Effect of N-acetylcysteine, an inhibitor of tumor necrosis factor, on irritant contact dermatitis in the human","author":"Pasche-Koo","year":"1995","journal-title":"Curr Probl Dermatol"},{"key":"key-10.4103\/0378-6323.241953-47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1523-1747.2003.12122.x","article-title":"Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo","author":"Kang","year":"2003","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.241953-48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/lsm.1900160407","article-title":"Effect of N-acetylcyste\u00efne on photofrin-induced skin photosensitivity in patients","author":"Baas","year":"1995","journal-title":"Lasers Surg Med"},{"key":"key-10.4103\/0378-6323.241953-49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1751-1097.1994.tb05063.x","article-title":"Partial protection of photodynamic-induced skin reactions in mice by N-acetylcysteine: A preclinical study","author":"Baas","year":"1994","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0378-6323.241953-50","first-page":"86","article-title":"Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy","author":"Kim","year":"1983","journal-title":"Semin Oncol"},{"key":"key-10.4103\/0378-6323.241953-51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/cyto.1999.0566","article-title":"Vascular endothelial growth factor (VEGF) and melanoma.N-acetylcysteine downregulates VEGF production in vitro","author":"Redondo","year":"2000","journal-title":"Cytokine"},{"key":"key-10.4103\/0378-6323.241953-52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/ijms17030418","article-title":"Melanocytes affect nodal expression and signaling in melanoma cells: A lesson from pediatric large congenital melanocytic nevi","author":"Margaryan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key-10.4103\/0378-6323.241953-53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/14764172.2011.630088","article-title":"Melasma: Treatment strategy","author":"Sehgal","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"key-10.4103\/0378-6323.241953-54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1468-3083.1997.tb00238.x","article-title":"N-acetylcysteine as a bleaching agent in the treatment of melasma","author":"Njoo","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.241953-55","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2000.03393.x","article-title":"Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: Report of two cases","author":"Vadoud-Seyedi","year":"2000","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.241953-56","first-page":"64","article-title":"A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine","author":"Cooke","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.241953-57","first-page":"271873","article-title":"Pseudoporphyria associated with nonhemodialyzed renal insufficiency, successfully treated with oral N-acetylcysteine","author":"Katoulis","year":"2013","journal-title":"Case Rep Dermatol Med"},{"key":"key-10.4103\/0378-6323.241953-58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/ard.38.4.356","article-title":"Measurement of clinical change in progressive systemic sclerosis: A 1 year double-blind placebo-controlled trial of N-acetylcysteine","author":"Furst","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0378-6323.241953-59","first-page":"2257","article-title":"Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study","author":"Sambo","year":"2001","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0378-6323.241953-60","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10067-009-1251-7","article-title":"The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: A prospective observational study of 50 patients","author":"Rosato","year":"2009","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/0378-6323.241953-61","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.241953-62","first-page":"483","article-title":"The effect of high dose of N-acetylcysteine in lupus nephritis: A case report and literature review","author":"Tewthanom","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0378-6323.241953-63","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.241953-64","first-page":"606, 608","article-title":"Successful treatment of non-healing pressure ulcers with topical n-acetyl cysteine","author":"Ozkaya","year":"2015","journal-title":"J Wound Care"},{"key":"key-10.4103\/0378-6323.241953-65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.burns.2012.06.015","article-title":"An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine","author":"Deniz","year":"2013","journal-title":"Burns"},{"key":"key-10.4103\/0378-6323.241953-66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/08941939.2011.560237","article-title":"N-acetyl-cysteine improves anastomotic wound healing after radiotherapy in rats","author":"Demir","year":"2011","journal-title":"J Invest Surg"},{"key":"key-10.4103\/0378-6323.241953-67","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1365-2230.2010.03823.x","article-title":"N-acetyl cysteine promotes angiogenesis and clearance of free oxygen radicals, thus improving wound healing in an alloxan-induced diabetic mouse model of incisional wound","author":"Aktunc","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.241953-68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/039463201302600128","article-title":"Ulcers caused by bullous morphea: Successful therapy with N-acetylcysteine and topical wound care","author":"Rosato","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key-10.4103\/0378-6323.241953-69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejogrb.2011.07.005","article-title":"Clinical, endocrine and metabolic effects of metformin vs.N-acetyl-cysteine in women with polycystic ovary syndrome","author":"Oner","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/0378-6323.241953-70","first-page":"817849","article-title":"N-acetylcysteine for polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled clinical trials","author":"Thakker","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"key-10.4103\/0378-6323.241953-71","first-page":"5","article-title":"Effect of oral antioxidants on lesion counts associated with oxidative stress and inflammation in patients with papulopustular acne","author":"Sahib","year":"2012","journal-title":"J Clin Exp Dermatol Res"},{"key":"key-10.4103\/0378-6323.241953-72","first-page":"348","article-title":"Topical acne treatment with acetylcysteine: Clinical and experimental effects","author":"Montes","year":"2012","journal-title":"Skinmed"},{"key":"key-10.4103\/0378-6323.241953-73","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/jid.2015.28","article-title":"Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia","author":"Upton","year":"2015","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.241953-74","first-page":"217","article-title":"Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice","author":"D'Agostini","year":"1998","journal-title":"Int J Oncol"},{"key":"key-10.4103\/0378-6323.241953-75","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/jid.2008.122","article-title":"Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: Implications for psoriasis and inflammatory skin disease","author":"Young","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.241953-76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0196-0644(00)70056-4","article-title":"Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: A randomized controlled trial","author":"Tanen","year":"2000","journal-title":"Ann Emerg Med"},{"key":"key-10.4103\/0378-6323.241953-77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3476(98)70501-3","article-title":"Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: Results of an open-label, clinical trial","author":"Perry","year":"1998","journal-title":"J Pediatr"},{"key":"key-10.4103\/0378-6323.241953-78","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/15563650802245497","article-title":"Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose","author":"Pakravan","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"key-10.4103\/0378-6323.241953-79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650802665587","article-title":"Adverse reactions associated with acetylcysteine","author":"Sandilands","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"key-10.4103\/0378-6323.241953-80","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0735-1097(97)00005-3","article-title":"Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris","author":"Ardissino","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0378-6323.241953-81","first-page":"253","article-title":"A double-blind, cross-over, study of oral N-acetylcysteine in Sj\u00f6gren's syndrome","author":"Walters","year":"1986","journal-title":"Scand J Rheumatol Suppl"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T16:03:27Z","timestamp":1720627407000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/n-acetylcysteine-in-dermatology\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"alternative-id":["241953"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_33_18","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}